作者的详细信息

Antsiferov, M

期 栏目 标题 文件
编号 3 (2009) Articles Vildagliptin - a new dipeptidylpeptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
编号 3 (2009) Articles Prospects of the first human glucagon-like peptide 1 analog liraglutid use in the treatment of patients with type 2 diabetes mellitus
编号 3 (2009) Articles Experience of incritinomimetic exenatide (Byetta) use in the treatment of patients with type 2 diabetes mellitus with obesity
编号 3 (2009) Articles Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL
编号 3 (2009) Articles Effect of alpha-lipoic acid (Tiogamma) on the quality of life of patients with diabetic peripheral polyneuropathy
编号 17 (2009) Articles ROSIGLITAZON: BEZOPASNOST', EFFEKTIVNOST' I VLIYaNIE NA KARDIOVASKULYaRNYE ISKhODY U PATsIENTOV S SAKhARNYM DIABETOM TIPA 2
编号 17 (2009) Articles DIABETIChESKAYa PERIFERIChESKAYa POLINEVROPATIYa: SOVREMENNYE PREDSTAVLENIYa O PATOGENEZE I PODKhODY K TERAPII
编号 17 (2009) Articles INNOVATsIONNYY KOMBINIROVANNYY PREPARAT GALVUS MET (VILDAGLIPTIN + METFORMIN) V LEChENII SAKhARNOGO DIABETA TIPA 2
编号 17 (2009) Articles GLIKEMIChESKIY KONTROL' U PATsIENTOV S SAKhARNYM DIABETOM TIPA 2 VO VREMYa INITsIATsII INSULINOTERAPII V REAL'NOY KLINIChESKOY PRAKTIKE ROSSIYSKOY FEDERATsII: REZUL'ATY ISSLEDOVANIYa CREDIT
编号 3 (2010) Articles Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
编号 3 (2010) Articles New possibilities for diabetic peripheral neuropathy treatment
编号 11 (2010) Articles Role of the long-acting somastatin analogue Sandostatin Lar in the treatment of acromegaly
编号 16 (2010) Articles POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
编号 16 (2010) Articles CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS
编号 16 (2010) Articles ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
编号 3 (2011) Articles TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS
编号 3 (2011) Articles INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
编号 3 (2011) Articles CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
编号 3 (2011) Articles CENTRAL DIABETES INSIPIDUS: MODERN CONCEPTS AND THERAPEUTIC APPROACHES
编号 3 (2012) Articles GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
编号 3 (2012) Articles TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
编号 3 (2012) Articles APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
编号 3 (2012) Articles HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?
编号 7 (2012) Articles DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
编号 7 (2012) Articles DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY?
##common.cookie##